Research Reports

Summary

Encompass Health Corporation held its Annual Meeting on May 7, 2026, where stockholders elected all ten director nominees, ratified PricewaterhouseCoopers LLP as the independent auditor, and approved executive compensation, with voting participation representing 92.5% of the common stock's combined voting power.

Key takeaways

All ten director nominees were elected, with vote support ranging from 92.5% to 96.1% of votes cast; reflects strong board continuity.

Ratification of PricewaterhouseCoopers LLP as independent auditor passed with 95.9% of votes cast in favor; confirms audit firm continuity.

Say-on-pay proposal for named executive officer compensation passed with 96.3% of votes cast in favor; signals broad shareholder alignment with pay practices.

Broker non-votes totaled 5,601,574 for both director elections and executive compensation approval, but none for auditor ratification.

99,565,304 shares of common stock were outstanding as of the record date, each entitled to one vote; common stock voted as a single class.

Full analysis

The Annual Meeting results reflect stable corporate governance and investor confidence in Encompass Health’s leadership and executive compensation framework. All ten director nominees were elected with strong majority support—no nominee received less than 92.5% of votes cast, and the highest opposition was 3.1% (for Greg D. Carmichael). Auditor ratification achieved 95.9% support, consistent with historical continuity and absence of audit-related controversies. The say-on-pay proposal passed with 96.3% support, indicating alignment between executive pay disclosures in the April 7, 2026 proxy statement and shareholder expectations. Broker non-votes applied only to Proposals 1 and 3, as permitted under NYSE rules for routine matters, but not Proposal 2—an important distinction confirming that auditor ratification is considered a non-routine matter requiring discretionary voting. With 92.5% of voting power represented by proxy, turnout was robust, though the filing does not disclose in-person attendance or dissenting institutional voting patterns. No changes to board composition, audit firm, or compensation policy were indicated, underscoring operational and governance continuity.